GlobeNewswire

Nexstim Receives an NBS System Order from a University Hospital in Germany

Share

Press release, Helsinki, 29 July 2021 at 10 AM(EEST)

Nexstim Receives an NBS System Order froma University Hospital in Germany

Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces that it has received an NBS System order in Germany. The customer is a German university hospital and a new customer for Nexstim.

Nexstim NBS systems with SmartFocus® nTMS technology are mainly used for neurosurgical diagnostics: One of the most crucial pieces of information needed for neurosurgery or radiotherapy is the tumor’s or other lesion’s location in relation to the essential functions and their connections in the patient’s brain. SmartFocus® nTMS mapping with Nexstim’s NBS system can give this information regarding motor and speech areas — it can be invaluable when deciding the best treatment option.

Mikko Karvinen, CEO of Nexstim commented:We are very happy about our continued success in expanding our NBS presence within the German university hospitals. This sale is a good start to the second half of the financial year. Along with recurring revenue from our existing installed base, new customers help us grow our business and make our technology available to more and more healthcare professionals and patients around the world.

Further information is available on the website www.nexstim.com, or by contacting:

Mikko Karvinen, CEO
+358 50 326 4101
mikko.karvinen@nexstim.com

About Nexstim Plc

Nexstim is a Finnish, globally operating medical technology company. Our mission is to enable personalized and effective therapies and diagnostics for challenging brain diseases and disorders.

Nexstim has developed a world-leading non-invasive brain stimulation technology called SmartFocus®. It is a navigated transcranial magnetic stimulation (nTMS) technology with highly sophisticated 3D navigation providing accurate and personalized targeting of the TMS to the specific area of the brain.

SmartFocus® technology is used in Nexstim’s proprietary Navigated Brain Therapy (NBT®) system, which is FDA cleared for marketing and commercial distribution for the treatment of major depressive disorder (MDD) in the United States. In Europe, the NBT® system is CE marked for the treatment of major depression and chronic neuropathic pain.

In addition, Nexstim is commercializing its SmartFocus® based Navigated Brain Stimulation (NBS) system for diagnostic applications. The NBS system is the only FDA cleared and CE marked navigated TMS system for pre-surgical mapping of the speech and motor cortices of the brain. Nexstim shares are listed on the Nasdaq First North Growth Market Finland and Nasdaq First North Growth Market Sweden.

For more information please visit www.nexstim.com

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

CORRECTION: Huhtamaki completes the acquisition of Elif, a major supplier of sustainable flexible packaging to global brand owners23.9.2021 19:15:00 CEST | Press release

HUHTAMÄKI OYJ PRESS RELEASE 23.9.2021 AT 20:15 CORRECTION: Huhtamaki completes the acquisition of Elif, a major supplier of sustainable flexible packaging to global brand owners In Huhtamäki Oyj’s press release concerning the closure of the acquisition of Elif published on September 23, 2021 at 17:30 EET, the cash free debt free purchase price was incorrect. The incorrect sentence was: The cash free debt free purchase price was EUR 360 million (USD 422 million). The correct sentence is: The cash free debt free purchase price was EUR 412 million (USD 483 million). Below the corrected release in full: Further to the full approval of the Turkish competition authority Huhtamaki has completed the acquisition of Elif Holding A.Ş. (Elif), a major supplier of sustainable flexible packaging to global FMCG brand owners, with operations in Turkey and in Egypt. With this acquisition, Huhtamaki reinforces its position as a leading flexible packaging company in emerging markets and strengthens its e

SBM Offshore completes US$635 million bridge loan for FPSO Almirante Tamandaré23.9.2021 18:40:20 CEST | Press release

September 23, 2021 SBM Offshore is pleased to announce that it has secured a US$635 million bridge loan facility for the financing of the construction of FPSO Almirante Tamandaré. The facility was secured by the special purpose company which will own FPSO Almirante Tamandaré. Currently, SBM Offshore is the sole owner of this special purpose company. Discussions around the divestment of 45% of the equity ownership to partners continue to progress. The facility will be fully drawn in the coming days to finance the ongoing construction of the FPSO Almirante Tamandaré. The tenor of the bridge loan is twelve months with an extension option for another six months. Repayment is expected to take place upon closure and first drawdown of the project loan. CorporateProfile The Company’s main activities are the design, supply, installation, operation and the life extension of floating production solutions for the offshore energy industry over the full lifecycle. The Company is market leading in le

Beter Bed category winner best webshop of the year!23.9.2021 18:30:00 CEST | Press release

Sleep specialist Beter Bed was today voted category winner of the ‘ABN AMRO Webshop Award in the Netherlands’ for the fifth time. Beter Bed is now a nominee for the overall winner of the ‘ABN AMRO Best Retail Chain Award in the Netherlands’. The announcements were made during the category presentation ceremony for the ‘ABN AMRO Retailer of the Year the Netherlands’, at the ABN AMRO head office in Amsterdam. Beter Bed received the highest score from the consumer panel in the Web shop category, beating off competition from other webshops in the Sleeping category. John Kruijssen, CEO of Beter Bed Holding, is delighted and proud that Beter Bed was once again awarded the Webshop Award. “Within our omni-channel strategy the digital channel is becoming increasingly important, as is confirmed by our customers with this award. This title will be a real boost to the launch of our digital organisation under the name LUNEXT. LUNEXT, Beter Bed’s new employer brand, will serve as the vehicle for the

ORANGE BELGIUM LAUNCHES HEY! A NEW, 100% DIGITAL BRAND AIMED AT ULTRA-CONNECTED CUSTOMERS23.9.2021 18:10:00 CEST | Press release

Press release Brussels, September 23rd , 2021 With its new positioning Tomorrow is ours to make, Orange Belgium goes one step further in addressing all customer needs via the launch of a new and innovative b-brand to answer the needs of digital-savvy customers. hey! is a 100% digital brand which takes a participative approach specially designed to meet the needs of ultra-connected customers whose life is completely digitally oriented. This next generation value proposition is based on 4 pillars: 100% digital, Generous,Low impact, Evolutive. hey! will shake up the market by putting communities at the heart of its offers. The threehey! offers which boast attractiveonline pricing with extensive mobile data , will be launched on the 24th of September 2021. 100% digital hey! meets the needs generated by new internet usages, which have become increasingly popular, particularly among digitally active customers. hey! is aimed at those who love efficiency and getting things done in a few clicks

Medela’s Global Breastfeeding Symposium Convenes Community Focused on Establishing a Perpetual and Holistic Model to Advance Breastfeeding and Lactation Research23.9.2021 17:17:22 CEST | Press release

Call to Action for Researchers and Healthcare Professionals to Improve Infant Health Outcomes by Protecting and Promoting Breastfeeding Baar, Switzerland, Sept. 23, 2021 (GLOBE NEWSWIRE) -- *the English version shall prevail. Medela, a leading breast pump brand and medical device manufacturer, concluded its 15th Global Breastfeeding and Lactation Symposium with 1,400 people tuning in virtually from around the world. Medela convened a diverse group of global health leaders and lactation experts to share the latest research and insights in lactation and human milk, empowering the lactation and breastfeeding community with key information to support a strong call to action: respond to future pandemic threats with lactation needs in mind, improve clinical practice, better care for breastfeeding families and drive change. “There is power in bringing the top minds together to focus on improving infant and women’s health. Over the past two days, leading scientists from six countries shared th

Huhtamaki completes the acquisition of Elif, a major supplier of sustainable flexible packaging to global brand owners23.9.2021 16:30:00 CEST | Press release

HUHTAMÄKI OYJ PRESS RELEASE 23.9.2021 AT 17:30 Huhtamaki completes the acquisition of Elif, a major supplier of sustainable flexible packaging to global brand owners Further to the full approval of the Turkish competition authority Huhtamaki has completed the acquisition of Elif Holding A.Ş. (Elif), a major supplier of sustainable flexible packaging to global FMCG brand owners, with operations in Turkey and in Egypt. With this acquisition, Huhtamaki reinforces its position as a leading flexible packaging company in emerging markets and strengthens its existing flexible packaging business in attractive consumer product categories. The net sales of the acquired business were approximately EUR 163 million (USD 195 million) in 2020. Elif employs approximately 1,500 people in its two manufacturing locations in Istanbul, Turkey and Cairo, Egypt. The cash free debt free purchase price was EUR 360 million (USD 422 million). The acquired business will be reported as part of Huhtamaki´s Flexible